|
ZDHHC13 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.837800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.869400E-01 |
| Normal-vs-Stage2 |
4.595600E-01 |
| Normal-vs-Stage3 |
3.274800E-01 |
| Normal-vs-Stage4 |
8.155800E-01 |
| Stage1-vs-Stage2 |
4.506800E-01 |
| Stage1-vs-Stage3 |
2.959000E-01 |
| Stage1-vs-Stage4 |
7.356000E-01 |
| Stage2-vs-Stage3 |
9.050400E-01 |
| Stage2-vs-Stage4 |
4.695400E-01 |
| Stage3-vs-Stage4 |
3.629600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.299600E-01 |
| Normal-vs-AfricanAmerican |
2.454400E-01 |
| Normal-vs-Asian |
2.473500E-02 |
| Caucasian-vs-AfricanAmerican |
7.242500E-02 |
| Caucasian-vs-Asian |
1.152010E-02 |
| AfricanAmerican-vs-Asian |
1.748620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.559400E-01 |
| Normal-vs-Female |
6.060200E-03 |
| Male-vs-Female |
1.9538499999916E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.054000E-01 |
| Normal-vs-Extreme_Weight |
4.885400E-01 |
| Normal-vs-Obese |
8.035400E-01 |
| Normal-vs-Extreme_Obese |
6.435400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.457250E-01 |
| Normal_Weight-vs-Obese |
7.439800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.315600E-01 |
| Extreme_Weight-vs-Obese |
2.395000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.169800E-01 |
| Obese-vs-Extreme_Obese |
5.330600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.088480E-02 |
| Normal-vs-Age(41-60Yrs) |
5.324800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.124400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.795760E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.543540E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.839800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.363030E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.176840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.950000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.621600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.606200E-01 |
| Normal-VS-Type2 PRCC |
5.525600E-01 |
| Normal-VS-KIRP CIMP |
2.772800E-04 |
| Normal-VS-Unclassified PRCC |
1.955960E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.782200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.982100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.313700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.906100000035E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
3.494100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.122800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.626400E-01 |
| Normal-vs-N1 |
9.816100E-02 |
| Normal-vs-N2 |
9.656200E-01 |
| N0-vs-N1 |
1.559630E-02 |
| N0-vs-N2 |
7.274200E-01 |
| N1-vs-N2 |
5.063000E-01 |
|
|
